Healthy volunteers test new Drug's body effects
NCT ID NCT07133191
First seen Oct 31, 2025 · Last updated Jun 15, 2026 · Updated 40 times
Summary
This study is for research only and does not treat any disease. It looks at how a single 16 mg dose of selatogrel is absorbed, broken down, and tolerated in 32 healthy adults—16 Japanese and 16 Caucasian. Participants stay in a clinic for 3-4 days and have follow-up visits over about 70 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CenExel ACT (Anaheim Clinical Trials)
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.